Publications by the researcher in collaboration with CRISTINA JIMÉNEZ LUNA (18)

2024

  1. Metastatic pancreatic and lung cancer patient in complete remission following immunotherapy: A case report and review of literature

    World Journal of Gastrointestinal Oncology, Vol. 16, Núm. 5, pp. 2233-2240

2023

  1. Serum biomarkers for the differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma

    World Journal of Gastrointestinal Oncology, Vol. 15, Núm. 2, pp. 268-275

  2. Serum nuclear magnetic resonance metabolomics analysis of human metastatic colorectal cancer: Biomarkers and pathway analysis

    NMR in Biomedicine, Vol. 36, Núm. 9

2021

  1. Circulating ptgs2, jag1, gucy2c and pgf mrna in peripheral blood and serum as potential biomarkers for patients with metastatic colon cancer

    Journal of Clinical Medicine, Vol. 10, Núm. 11

  2. Liquid biopsy approach to pancreatic cancer

    World Journal of Gastrointestinal Oncology, Vol. 13, Núm. 10, pp. 1263-1287

  3. Untargeted metabolomics for the diagnosis of exocrine pancreatic insufficiency in chronic pancreatitis

    Medicina (Lithuania), Vol. 57, Núm. 9

2020

  1. Discovery of pancreatic adenocarcinoma biomarkers by untargeted metabolomics

    Cancers, Vol. 12, Núm. 4

  2. MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression

    Journal of Biosciences, Vol. 45, Núm. 1

  3. Novel biomarkers to distinguish between type 3c and type 2 diabetes mellitus by untargeted metabolomics

    Metabolites, Vol. 10, Núm. 11, pp. 1-12

  4. Role of exocrine and endocrine insufficiency in the management of patients with chronic pancreatitis

    Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-12

  5. State of the art in exocrine pancreatic insufficiency

    Medicina (Lithuania), Vol. 56, Núm. 10, pp. 1-10

2019

  1. Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers

    PLoS ONE, Vol. 13, Núm. 4

  2. Proteomic biomarkers in body fluids associated with pancreatic cancer

    Oncotarget, Vol. 9, Núm. 23, pp. 16573-16587

2017

  1. Untargeted LC-HRMS-based metabolomics for searching new biomarkers of pancreatic ductal adenocarcinoma: A pilot study

    SLAS Discovery, Vol. 22, Núm. 4, pp. 348-359

2016

  1. Current status of immunotherapy treatments for pancreatic cancer

    Journal of Clinical Gastroenterology, Vol. 50, Núm. 10, pp. 836-848

  2. Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinoma patients

    Toxicology and Applied Pharmacology, Vol. 311, pp. 113-116

2014

  1. Transcriptional Profiling of Peripheral Blood in Pancreatic Adenocarcinoma Patients Identifies Diagnostic Biomarkers

    Digestive Diseases and Sciences, Vol. 59, Núm. 11, pp. 2714-2720